An institutional experience with cervical vagus nerve trunk stimulation for medically refractory epilepsy: rationale, technique, and outcome
- PMID: 9848840
- DOI: 10.1097/00006123-199812000-00001
An institutional experience with cervical vagus nerve trunk stimulation for medically refractory epilepsy: rationale, technique, and outcome
Abstract
Objective: Intermittent stimulation of the left cervical vagus nerve trunk is emerging as a novel adjunct in the treatment of medically refractory seizures. We sought to evaluate theoretical and practical issues attendant to this concept. We review the anatomic and physiological background arguing for clinical application of vagus nerve stimulation, discuss salient aspects of patient selection and the nuances of surgical technique, and present our observations of and results from application of the method.
Methods: Each of 18 patients with medically refractory epilepsy and at least six complex partial or secondarily generalized seizures per month underwent placement of a NeuroCybernetic Prosthesis pulse generator (Cyberonics, Webster, TX) in the chest, connected to helical platinum leads applied to the left cervical vagus nerve trunk. The patients were then randomized in a double-blinded fashion to receive either high (presumably therapeutic) or low (presumably less therapeutic) levels of vagus nerve stimulation. Reduction in seizure frequency, global assessments of quality of life, physiological measurements, and adverse events were recorded during a 3-month period. Patients in the low group were then crossed over to high-stimulation paradigms during a 15-month extension trial.
Results: All operations were successful, uneventful, and without adverse postoperative sequelae. One patient was excluded from analysis because of inadequate seizure calendars. Of the seven patients initially assigned to high stimulation, the mean reduction in seizure frequency was 71% at 3 months and 81% at 18 months. Five (72%) of these patients had a greater than 75% reduction in seizure frequency, and one (14%) remained seizure-free after more than 1.5 years of follow-up. The mean reduction in seizure frequency among the low-stimulation group was only 6% at 3 months. No serious complications, device failures, or physiological perturbations occurred.
Conclusion: In our experience, vagus nerve stimulation has proven to be a safe, feasible, and potentially effective method of reducing seizures in select patient populations. However, the elements of strict definition for the application of the method require further study.
Similar articles
-
Long-term multicenter experience with vagus nerve stimulation for intractable partial seizures: results of the XE5 trial.Stereotact Funct Neurosurg. 1999;73(1-4):104-8. doi: 10.1159/000029764. Stereotact Funct Neurosurg. 1999. PMID: 10853111 Clinical Trial.
-
Right-sided vagus nerve stimulation in humans: an effective therapy?Epilepsy Res. 2008 Dec;82(2-3):232-4. doi: 10.1016/j.eplepsyres.2008.08.003. Epub 2008 Sep 18. Epilepsy Res. 2008. PMID: 18801642
-
Treatment of epilepsy by stimulation of the vagus nerve.Neurology. 1993 Jul;43(7):1338-45. doi: 10.1212/wnl.43.7.1338. Neurology. 1993. PMID: 8327135 Clinical Trial.
-
Vagus nerve stimulation therapy for seizures.J Neurosurg Anesthesiol. 2008 Jan;20(1):29-35. doi: 10.1097/ANA.0b013e31815b7df1. J Neurosurg Anesthesiol. 2008. PMID: 18157022 Review.
-
Vagus nerve stimulation for the treatment of intractable epilepsy.Expert Rev Neurother. 2007 Dec;7(12):1763-73. doi: 10.1586/14737175.7.12.1763. Expert Rev Neurother. 2007. PMID: 18052768 Review.
Cited by
-
Harnessing the Inflammatory Reflex for the Treatment of Inflammation-Mediated Diseases.Cold Spring Harb Perspect Med. 2020 Jan 2;10(1):a034330. doi: 10.1101/cshperspect.a034330. Cold Spring Harb Perspect Med. 2020. PMID: 30833463 Free PMC article. Review.
-
Vagal nerve stimulator: Evolving trends.J Nat Sci Biol Med. 2013 Jan;4(1):8-13. doi: 10.4103/0976-9668.107254. J Nat Sci Biol Med. 2013. PMID: 23633829 Free PMC article.
-
Early postnatal overnutrition: potential roles of gastrointestinal vagal afferents and brain-derived neurotrophic factor.Physiol Behav. 2012 Jun 6;106(3):400-12. doi: 10.1016/j.physbeh.2012.04.002. Physiol Behav. 2012. PMID: 22712064 Free PMC article. Review.
-
Efficiency of surgery on posttraumatic epilepsy: a systematic review and meta-analysis.Neurosurg Rev. 2023 Apr 18;46(1):91. doi: 10.1007/s10143-023-01997-3. Neurosurg Rev. 2023. PMID: 37071216
-
Minimally invasive surgical approaches for temporal lobe epilepsy.Epilepsy Behav. 2015 Jun;47:24-33. doi: 10.1016/j.yebeh.2015.04.033. Epub 2015 May 24. Epilepsy Behav. 2015. PMID: 26017774 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical